Skip to main content
Screener/Healthcare/Biotechnology

KRYS — Krystal Biotech, Inc.

NASDAQ
$301.50+1.25 (+0.41%)
Mid CapHealthcareFastest GrowingLow BetaMost Profitable
$192.52
$382.54
$297.52
$305.60
EPS (TTM)$7.48
P/E Ratio40.31
Dividend Yield—
Market Cap$9.84B
Volume121K
Prev Close$300.25
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$116.4M$55.9M$1.8394.6%48.1%
Q4 '25$107.1M$51.4M$1.7089.8%48.0%
Q3 '25$97.8M$79.4M$2.6694.2%81.2%
Q2 '25$96.0M$38.3M$1.2992.5%39.9%
Q1 '25$88.2M$35.7M$1.2094.3%40.5%
Q4 '24$91.1M$45.5M$1.5294.6%49.9%
Q3 '24$83.8M$27.2M$0.9192.0%32.4%
Q2 '24$70.3M$15.6M$0.5391.5%22.2%
Get Your Daily Market Recap